fashion -WSS

fashion

author：comprehensive 2025-09-30 15:16:09 - browse：791

Who polices algorithms? How would you name the first approved CRISPR medicine? And what pairs well with a biotech downturn?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Casey Ross joins us to tell the bombshell story of how the nation’s largest health insurer used a computer algorithm to deny patient care and boost its profitability. Then, biotech veteran Michael Gilman calls in to offer a behind-the-scenes peek at what it’s like to be a startup CEO in this economic downturn — and which cocktail recipes help make it bearable. We also discuss a pioneering approval for a genome-editing medicine.

For more on what we cover, here’s the UnitedHealth story; here’s more on the CRISPR approval; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Retired US general questions alleged Putin, Prigozhin meeting

hotspot

entertainment

WSS

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Ventyx halts psoriasis drug development after lackluster trial results

A letter from the executive editor: STAT UnitedHealth investigation

HCA discloses massive data breach affecting 11 million patients

Study suggests Covid rebound is far more common with Paxlovid than without

knowledge

fashion

hotspot

In age of alternative facts, a scholarly course on calling out crap

Readout Newsletter: Zepbound, Valneva's vaccine, and more

At least 13 dead in Texas as scorching temps continue

Charles Manson follower Leslie Van Houten released from prison after 53 years

Medicare details structure of new drug price negotiation program

Ventyx halts psoriasis drug development after lackluster trial results

In Memoriam: Notable people who died in 2023

NIH chief: government has fallen behind pharma on clinical trials

At least 13 dead in Texas as scorching temps continue

HCA discloses massive data breach affecting 11 million patients

hotspot

White House drug czar issues call for 'recovery

Ohio still needs to do more to protect the right to abortion

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Petition to FDA: Get the lead out of consumer hair dyes

Leqembi, other new Alzheimer’s drugs require better biomarkers

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

leisure time

hotspot

entertainment

knowledge